Sort
30,917 grants matching “tumor microenvironment”
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
$871,044Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2021 · CA
Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies
$870,353David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
The Role of Inflammation and Stroma in Digestive Cancer
$870,263Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2007 · CA
Signal Transduction Events and the Regulation of Cell Growth
$870,159Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2016 · CA
Biology of Mammary Gland Development and Tumorigenesis
$869,992Gilbert Smith · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Bladder Cancer Program
$869,986Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Integrating tumor and stroma to understand and predict treatment response
$869,831Jen Jen Yeh · Univ Of North Carolina Chapel Hill · U01 · FY2024 · CA
Biology of Mammary Gland Development and Tumorigenesis
$869,752Gilbert Smith · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$869,296Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Spatial omics technologies to map the senescent cell microenvironment
$868,367Nicola Neretti · Brown University · UH3 · FY2023 · CA
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$867,492Jyothi Rengarajan · Emory University · R01 · FY2023 · AI
Stromal Regulation of Bone Metastasis
$866,890Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
A novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer
$866,737Jennifer June Sessions · Cynvec, Llc · R44 · FY2022 · CA
Targeting Nucleotide Excision Repair Deficiency to Improve Bladder Sparing Treatment for Muscle Invasive Bladder Cancer
$866,727Kent W Mouw · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Microenvironmental regulation of glioblastoma radiosensitivity
$866,564Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$866,476Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Functional Analysis of TEM5 and TEM8
$866,275Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Studies of Human T Regulatory Cells
$866,060Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2024 · CA
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2023 · CA
Development of Drugs Acting at Adenosine Receptors
$865,266Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$865,070Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2021 · CA
Human pluripotent stem cells
$865,069Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS
Preclinical Development of a Novel and Powerful Immunotherapeutic
$864,478Susan Dana Jones · Immurx Llc · R44 · FY2013 · AI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
$864,084Bing Zhang · Baylor College Of Medicine · U24 · FY2023 · CA